
Publication|Articles|October 10, 2025
- October 2025
- Volume 91
- Issue 10
FDA Approvals for September 2025
Author(s)PT Staff
Key Takeaways
- Recent FDA approvals highlight advancements in oncology, focusing on therapies targeting specific genetic mutations for personalized treatment.
- Expedited review processes by the FDA have enabled quicker access to innovative cancer treatments, improving patient outcomes.
Explore recent FDA-approved drugs from September 2025.
Advertisement
FDA Approvals
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Agonists May Interfere with PET-CT Scan Interpretation
2
Medicaid Expansion Can Improve 5-Year Survival Outcomes in Patients With Cancer
3
Tramadol and Antidepressants Linked to Increased Seizure Risk in Older Adults
4
Study Highlights Safety Concerns With Tramadol, Calls for Careful Prescribing
5